Because 3M's overall average analyst price target sits only modestly above the latest price, this analysis applies a minimum-distance rule: the central target is the arithmetic mean of verified targets that are above the current price. Reviewing roughly eleven current, attributable targets, the full range runs from $132 (RBC Capital, Underperform) to $218 (UBS, Buy). The overall mean of all valid targets is approximately $181, while the average of only the above-price targets comes to about $185, which is the figure used here.
Views are unusually split. Constructive analysts such as Goldman Sachs ($202, Buy), Barclays ($190, Overweight), J.P. Morgan ($185, Overweight), and Wells Fargo ($183, Buy) emphasize improving execution under CEO Bill Brown. More cautious names — Citi ($183, Neutral), Mizuho ($180), Bernstein ($171, Market Perform), and Morgan Stanley ($165, Equal Weight) — acknowledge better results but question whether current multiples leave enough room. The breadth between $132 and $218 means the average analyst price target should be read as a midpoint of debate, not a guarantee.
With shares last around $164.75, the move to $185 represents a required upside of approximately 12.3%. That qualifies as a substantial move rather than a trivial one, though it sits well inside the stock's normal annual range. The 52-week span has stretched from roughly $139 to about $185, meaning the central target coincides with the upper boundary of the past year's trading.
The possible path is anchored in fundamentals rather than pure momentum. 3M reported a second-quarter 2026 earnings beat, with organic growth of about 5.4% and segment EBIT (earnings before interest and taxes) running ahead of consensus, supporting raised full-year guidance. Analysts note new products introduced in the last five years growing at a strong clip and improving delivery metrics. A higher target would most plausibly require continued mid-single-digit organic growth plus modest multiple expansion, neither of which is assured.
The $185 level acts as both a psychological round-number target and a prior resistance zone, given it marks the upper end of the 52-week range. The 200-day moving average near $160 has provided underlying support, while the stock has recently traded below its 50-day average around $170, suggesting the shares remain in a consolidation phase rather than a decisive uptrend. A sustained push toward $185 would require clearing that $170–$171 area first.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms vary, and this article does not assign a specific timeline. Investors weighing the stock forecast should watch quarterly earnings and full-year guidance, any further analyst target revisions, PFAS litigation developments, and industrial-sector data on demand and channel inventories. Interest-rate decisions can also influence valuation multiples for a diversified manufacturer like 3M.
For traders seeking an objective, data-driven complement to fundamental research, AI Daily Buy/Sell Signals from Tickeron uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. These signals can help traders discover opportunities, monitor positions, and spot shifting trends more efficiently than manual scanning. Traders interested in a systematic edge can explore the tool to see how its models are currently reading MMM.
The central target of $185 — the average of analyst price targets above the current price — sits about 12% above the latest level near $164.75, a substantial but not extreme move. The bull case rests on a genuine operational turnaround, improving organic growth, and raised guidance, while the bear case points to an elevated valuation and a wide, skeptical distribution of analyst opinions, including RBC Capital's $132 Underperform view. With targets ranging from $132 to $218, there is no analyst consensus on the exact destination, only a broad debate about how much 3M's recovery is worth. Whether shares reach $185 will likely depend on sustained execution and whether the market is willing to pay a higher multiple for it.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MMM has been loosely correlated with MDU. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MMM jumps, then MDU could also see price increases.
| Ticker / NAME | Correlation To MMM | 1D Price Change % |
|---|---|---|
| MMM | 100% | -1.20% |
| Industrial Conglomerates industry (29 stocks) | 16% Poorly correlated | +0.72% |
| Producer Manufacturing industry (347 stocks) | 4% Poorly correlated | -0.64% |